Clinical Trial Update: Ketorolac on Posterior Thoracolumbar Spinal Fusions [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update regarding the use of ketorolac in posterior thoracolumbar spinal fusion procedures. The trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thoracolumbar Spinal Fusions

Drugs mentioned

• Ketorolac (Ketorolac tromethamine)

Snippet

Sponsor: Henry Ford Health System | Conditions: Thoracolumbar Spinal Fusions | Phase 4 | Status: UNKNOWN